MiNK Therapeutics, Inc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
MiNK Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • MiNK Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 99.8 %, a 92.7% decline year-over-year.
  • MiNK Therapeutics, Inc. annual Return On Equity for 2023 was 197 %.
  • MiNK Therapeutics, Inc. annual Return On Equity for 2022 was -300 %, a 529% decline from 2021.
  • MiNK Therapeutics, Inc. annual Return On Equity for 2021 was 69.9 %, a 104% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 197 +497 Jan 1, 2023 Dec 31, 2023
2022 -300 -370 -529% Jan 1, 2022 Dec 31, 2022
2021 69.9 +35.6 +104% Jan 1, 2021 Dec 31, 2021
2020 34.2 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.